EMFLAZA® safety profile
EMFLAZA does have a risk of side effects. Please seek treatment immediately and tell your child's healthcare provider if your child has any of these symptoms or any other side effects.
|Common side effects with EMFLAZA||Deflazacort 0.9 mg/kg/day (n=51) % at 12 weeks||Placebo (n=50) % at 12 weeksa|
|Facial puffiness or Cushingoid appearance||33%||12%|
|Frequent daytime urination||12%||6%|
|Upper respiratory tract infection||12%||2%|
|Unwanted hair growth||10%||6%|
- At 12 weeks placebo patients were re-randomized to receive either EMFLAZA or an active comparator.